Cargando…

HTLV-1 associated myelopathy of rapid onset and progression following living-donor kidney transplant: Clinical description and initial response to empirical treatment

Detalles Bibliográficos
Autores principales:	Gonzales, Liliana, Alave, Jorge L, Paredes, Mario, Molina, Carlos, Lopez, Giovanni, Alvarez, Carolina, Tipismana, Martin, Gotuzzo, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112770/ http://dx.doi.org/10.1186/1742-4690-8-S1-A56

Ejemplares similares

Changes in proviral load (PVL) among patients with rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) receiving empirical therapy
por: Gotuzzo, Eduardo, et al.
Publicado: (2011)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis
por: Julca-Copello, Pablo, et al.
Publicado: (2020)

Pattern mRNA expression similarities between ATL patients and patients coinfected with HTLV-I-Strongyolides stercoralis
por: Talledo, Michael, et al.
Publicado: (2011)

HTLV-1 infection and associated diseases in Peruvian twins probably exposed to HTLV-1 mother-to-child transmission
por: Alvarez, Carolina, et al.
Publicado: (2011)

Bibliometric description of the literature on HTLV-1 registered in PubMed over the past ten years
por: Verdonck, Kristien, et al.
Publicado: (2011)

Host genetic factors associated to proviral load in Peruvian HTLV-1 infected
por: Talledo, Michael, et al.
Publicado: (2011)

IL8 Gene Polymorphism SNP rs4073 analysis between HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis and HTLV-1 Carriers
por: Rúa, Jorge, et al.
Publicado: (2015)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul, et al.
Publicado: (2011)

HLA-G 14 bp insertion/deletion polymorphism is not associated to proviral load levels and presence of HAM/TSP in Peruvian HTLV-1 infected individuals
por: Morales, Sandra, et al.
Publicado: (2011)

Expression of hbz mRNA promotes survival in HTLV-1-infected cells with high DNA damage
por: Flores, Karina, et al.
Publicado: (2011)

Proviral load does not discriminate patients with Human T-Cell Leukemia/Lymphoma (ATLL) from HTLV-1 carriers with a history of Strongyloidiasis
por: López, Giovanni, et al.
Publicado: (2011)

Prevalence of XMRV in blood donors, HTLV and HIV cohorts
por: Qiu, Xiaoxing, et al.
Publicado: (2011)

NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
por: McCormick, Matthew, et al.
Publicado: (2011)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
por: Ueda, Koji, et al.
Publicado: (2011)

Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals
por: Roc, Lourdes, et al.
Publicado: (2019)

HTLV-1/2 prevalence in Brazilian blood donors: regional and demographic variation
por: Carneiro-Proietti, Anna B F, et al.
Publicado: (2011)

HTLV-I and –II seroprevalence among United States blood donors, 2000-2009
por: Kaidarova, Zhanna, et al.
Publicado: (2011)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

WHO antibody reference panel for donor screening assays that detect antibodies to human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)
por: Wigglesworth, Erin, et al.
Publicado: (2011)

Differential miRNA expression profiles in Peruvian HTLV-1 carriers
por: Rosado, Jason, et al.
Publicado: (2014)

Major depression and generalized anxiety disorder among HTLV-I/II infected former blood donors
por: Guiltinan, Anne M, et al.
Publicado: (2011)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Ascorbic Acid Has Superior Ex Vivo Antiproliferative, Cell Death-Inducing and Immunomodulatory Effects over IFN-α in HTLV-1-Associated Myelopathy
por: Moens, Britta, et al.
Publicado: (2012)

CD80(+) and CD86(+) B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
por: Menezes, Soraya Maria, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

HTLV-1 clonality during chronic infection and BLV clonality during primary infection
por: Gillet, Nicolas A, et al.
Publicado: (2011)

Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain
por: Treviño, Ana, et al.
Publicado: (2011)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
por: Araujo, Thessika H A, et al.
Publicado: (2011)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Cardiovascular risk profile in patients with myelopathy associated with HTLV-1()
por: Prado, Fabio Luís Silva do, et al.
Publicado: (2017)

Neurological disability in HTLV-1 infected individuals according to the initial clinical presentation: cohort study
por: Costa, Davi, et al.
Publicado: (2011)

Association between Human T-Cell Lymphotropic Virus Type 1 and 2 (HTLV 1/2) infection and tuberculosis: systematic review and meta-analysis
por: Arruda, Sérgio, et al.
Publicado: (2011)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

New insights into HTLV entry
por: Pique, Claudine, et al.
Publicado: (2011)

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamakawa, Natsuko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ds94ohha1dnoqecscv9p8o5rfa